Profile | GDS5420 / 208610_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1261.79 | 83 |
GSM1296119 | B_lesional_pre-dose | 452.9 | 66 |
GSM1296076 | C_lesional_pre-dose | 179.69 | 52 |
GSM1296092 | D_lesional_pre-dose | 221.53 | 56 |
GSM1296103 | E_lesional_pre-dose | 1699.22 | 87 |
GSM1296078 | F_lesional_pre-dose | 128.41 | 47 |
GSM1296107 | G_lesional_pre-dose | 683.83 | 73 |
GSM1296109 | H_lesional_pre-dose | 1356.5 | 84 |
GSM1296080 | I_lesional_pre-dose | 783.03 | 75 |
GSM1296090 | J_lesional_pre-dose | 218.56 | 55 |
GSM1296074 | K_lesional_pre-dose | 178.72 | 53 |
GSM1296111 | L_lesional_pre-dose | 525.8 | 69 |
GSM1296099 | M_lesional_pre-dose | 851.62 | 76 |
GSM1296086 | O_lesional_pre-dose | 292.62 | 60 |
GSM1296117 | P_lesional_pre-dose | 784.05 | 75 |
GSM1296113 | Q_lesional_pre-dose | 1152.39 | 82 |
GSM1296096 | R_lesional_pre-dose | 815.87 | 76 |
GSM1296105 | S_lesional_pre-dose | 1155.93 | 81 |
GSM1296098 | T_lesional_pre-dose | 2351.87 | 91 |
GSM1296101 | U_lesional_pre-dose | 1457.82 | 85 |
GSM1296121 | V_lesional_pre-dose | 572.17 | 70 |
GSM1296088 | W_lesional_pre-dose | 426.48 | 65 |
GSM1296082 | X_lesional_pre-dose | 190.15 | 53 |
GSM1296115 | Y_lesional_pre-dose | 733.33 | 74 |
GSM1296084 | Z_lesional_pre-dose | 404.52 | 64 |
GSM1296072 | B_lesional_day8 | 515.77 | 68 |
GSM1296069 | L_lesional_day8 | 595.43 | 70 |
GSM1296071 | P_lesional_day8 | 917.43 | 78 |
GSM1296070 | Y_lesional_day8 | 866.18 | 77 |
GSM1296073 | V_lesional_day8 | 350.28 | 62 |
GSM1296034 | A_lesional_day15 | 3385.15 | 96 |
GSM1296041 | G_lesional_day15 | 770.79 | 75 |
GSM1296035 | R_lesional_day15 | 1132.08 | 81 |
GSM1296038 | U_lesional_day15 | 866.27 | 77 |
GSM1296047 | B_lesional_day15 | 676.39 | 73 |
GSM1296039 | E_lesional_day15 | 612.66 | 72 |
GSM1296042 | H_lesional_day15 | 668.96 | 73 |
GSM1296043 | L_lesional_day15 | 911.4 | 78 |
GSM1296037 | M_lesional_day15 | 1402.87 | 85 |
GSM1296046 | P_lesional_day15 | 738.38 | 74 |
GSM1296044 | Q_lesional_day15 | 950.1 | 79 |
GSM1296045 | Y_lesional_day15 | 648.24 | 72 |
GSM1296025 | C_lesional_day15 | 895.5 | 77 |
GSM1296033 | D_lesional_day15 | 275.22 | 58 |
GSM1296027 | I_lesional_day15 | 295.85 | 60 |
GSM1296032 | J_lesional_day15 | 631.98 | 71 |
GSM1296024 | K_lesional_day15 | 961.17 | 78 |
GSM1296031 | W_lesional_day15 | 614.17 | 71 |
GSM1296028 | X_lesional_day15 | 430.56 | 65 |
GSM1296029 | Z_lesional_day15 | 561.34 | 69 |
GSM1296026 | F_lesional_day15 | 318.05 | 61 |
GSM1296030 | O_lesional_day15 | 284.46 | 59 |
GSM1296040 | S_lesional_day15 | 2075.11 | 90 |
GSM1296036 | T_lesional_day15 | 1937.87 | 89 |
GSM1296048 | V_lesional_day15 | 500 | 68 |
GSM1296059 | A_lesional_day43 | 1493.23 | 85 |
GSM1296066 | G_lesional_day43 | 764.06 | 75 |
GSM1296060 | R_lesional_day43 | 783.65 | 75 |
GSM1296063 | U_lesional_day43 | 549.29 | 70 |
GSM1296064 | E_lesional_day43 | 587.8 | 71 |
GSM1296067 | H_lesional_day43 | 966.73 | 79 |
GSM1296062 | M_lesional_day43 | 1818.9 | 88 |
GSM1296068 | Q_lesional_day43 | 1187.73 | 82 |
GSM1296050 | C_lesional_day43 | 298.58 | 59 |
GSM1296057 | D_lesional_day43 | 843.49 | 76 |
GSM1296052 | I_lesional_day43 | 309.42 | 60 |
GSM1296054 | J_lesional_day43 | 770.17 | 75 |
GSM1296049 | K_lesional_day43 | 577.6 | 70 |
GSM1296055 | W_lesional_day43 | 776.73 | 75 |
GSM1296053 | X_lesional_day43 | 642.32 | 71 |
GSM1296058 | Z_lesional_day43 | 737.52 | 74 |
GSM1296051 | F_lesional_day43 | 225.05 | 55 |
GSM1296056 | O_lesional_day43 | 530.16 | 69 |
GSM1296065 | S_lesional_day43 | 725.28 | 74 |
GSM1296061 | T_lesional_day43 | 2444.62 | 92 |
GSM1296095 | A_non-lesional_pre-dose | 892.75 | 77 |
GSM1296120 | B_non-lesional_pre-dose | 494.44 | 67 |
GSM1296077 | C_non-lesional_pre-dose | 718.24 | 74 |
GSM1296093 | D_non-lesional_pre-dose | 1085.86 | 81 |
GSM1296104 | E_non-lesional_pre-dose | 819.23 | 76 |
GSM1296079 | F_non-lesional_pre-dose | 404.81 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 864.02 | 77 |
GSM1296110 | H_non-lesional_pre-dose | 1163.66 | 82 |
GSM1296081 | I_non-lesional_pre-dose | 1174.96 | 81 |
GSM1296091 | J_non-lesional_pre-dose | 256.63 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 246.6 | 57 |
GSM1296112 | L_non-lesional_pre-dose | 932.05 | 78 |
GSM1296100 | M_non-lesional_pre-dose | 2097.86 | 90 |
GSM1296087 | O_non-lesional_pre-dose | 221.84 | 56 |
GSM1296118 | P_non-lesional_pre-dose | 1379.4 | 85 |
GSM1296114 | Q_non-lesional_pre-dose | 1090.62 | 81 |
GSM1296097 | R_non-lesional_pre-dose | 751.78 | 75 |
GSM1296106 | S_non-lesional_pre-dose | 1237.61 | 83 |
GSM1296102 | U_non-lesional_pre-dose | 1649.04 | 87 |
GSM1296122 | V_non-lesional_pre-dose | 670.08 | 73 |
GSM1296089 | W_non-lesional_pre-dose | 604.96 | 71 |
GSM1296083 | X_non-lesional_pre-dose | 1281.68 | 83 |
GSM1296116 | Y_non-lesional_pre-dose | 778.14 | 75 |
GSM1296085 | Z_non-lesional_pre-dose | 455.89 | 66 |